PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
91 hedge funds and large institutions have $154M invested in Poseida Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 86 → 91 (+5)
96% less call options, than puts
Call options by funds: $6K | Put options by funds: $156K
Holders
91
Holding in Top 10
2
Calls
$6K
Puts
$156K
Top Buyers
| 1 | +$3.37M | |
| 2 | +$1.13M | |
| 3 | +$1.04M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$672K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$605K |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$902K | |
| 3 | -$663K | |
| 4 |
Renaissance Technologies
New York
|
-$652K |
| 5 |
Squarepoint
New York
|
-$529K |